crinone 8%w/w vaginal gel
merck a e hellas - ΠΡΟΓΕΣΤΕΡΌΝΗ - vaginal gel - 8%w/w - 0000057830 - progesterone - 8 % w/w - progesterone
hydrocortisone 1% w/w cream
pinewood laboratories ltd (0000001597) ballymacarby, clonmel, co.tipperary - hydrocortisone micronised - cream - 1% w/w - hydrocortisone micronised (8000002705) 1% w/w - hydrocortisone
salbutamol 2mg/5ml σιροπι
pinewood laboratories ltd (0000001597) ballymacarby, clonmel, co.tipperary, . - salbutamol sulfate - ΣΙΡΟΠΙ - 2mg/5ml - salbutamol sulfate (0051022709) 2mg - salbutamol
teveten 600mg film coated tablets
viatris healthcare limited. (0000012172) damastown industrial park, mulhuddart, dublin 15, d15 xd71 - eprosartan - film coated tablets - 600mg - eprosartan (8000001766) 600mg - eprosartan
ursofalk 250mg capsule,hard
dr. falk pharma gmbh (0000008100) leinenweberstr. 5, freiburg, d-79108 - ursodeoxycholic acid - capsule,hard - 250mg - ursodeoxycholic acid (0000128132) 250mg - ursodeoxycholic acid
cortopin 1% w/w cream
pinewood laboratories ltd (0000001597) ballymacarby, clonmel, co.tipperary, . - hydrocortisone - cream - 1% w/w - hydrocortisone (0000050237) 1% w/w
scemblix
novartis europharm limited - asciminib hydrochloride - Λευχαιμία, μυελογενή, χρόνια, bcr-abl θετική - Αντινεοπλασματικοί παράγοντες - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.
livtencity
takeda pharmaceuticals international ag ireland branch - maribavir - Οι λοιμώξεις του κυτταρομεγαλοϊού - Αντιιικά για συστηματική χρήση - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). Πρέπει να ληφθούν υπόψη οι επίσημες οδηγίες για την κατάλληλη χρήση των αντι-ιικών παραγόντων.
adempas
bayer ag - riociguat - Υπέρταση, πνευμονική - Αντιϋπερτασικά για πνευμονική αρτηριακή υπέρταση - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. Η αποτελεσματικότητα έχει αποδειχθεί σε ΠΑΥ πληθυσμού, συμπεριλαμβανομένων αιτιολογίες ιδιοπαθής ή κληρονομική ΠΑΥ ή ΠΑΥ σχετιζόμενη με νόσο του συνδετικού ιστού. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.
deltyba
otsuka novel products gmbh - delamanid - Φυματίωση, ανθεκτική σε πολλαπλά φάρμακα - Αντιμικροβακτηριδια - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 και 5. Πρέπει να ληφθούν υπόψη οι επίσημες οδηγίες για την κατάλληλη χρήση των αντιβακτηριακών παραγόντων.